Drake & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Drake & Associates's JNJ Position: Q3 2026 in Review
Drake & Associates reduced its Johnson & Johnson (JNJ) stake by 23% in Q3 2026, selling an estimated $219K and leaving 2,735 shares worth $724K. The position accounts for 0.11% of the portfolio, ranked #55.
Drake & Associates first reported a position in JNJ in Q4 2022 and has held it in 16 quarters since. The position peaked at $3.32M in Q2 2025. 4,734 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.
- Drake & Associates held 2,735 shares of Johnson & Johnson worth $724K as of Q3 2026.
- Drake & Associates sold 830 Johnson & Johnson shares in Q3 2026, an estimated $219K.
- Johnson & Johnson made up 0.11% of Drake & Associates's portfolio in Q3 2026, its #55 holding.
- Drake & Associates first reported a position in Johnson & Johnson in Q4 2022 and has held it in 16 quarters since.
- Drake & Associates's Johnson & Johnson position peaked at $3.32M in Q2 2025.
- 4,734 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.
Based on Drake & Associates's 13F filing for Q3 2026, filed 18 Nov 2026.